glp-1 sleep apnea trial Tirzepatide for the Treatment of Obstructive and Obesity GLP-1 therapies reduce OSA risk
Description
Which is better: Foundayo or Oral Wegovy
Join us for an educational GLP-1 wellness workshop.
Gain a more in-depth understanding of past, current and future GLP-1 users
Doug Long, IQVIAs VP of Industry Relations, and Scott Biggs, the companys Director of Supplier Services, teamed in the presentation taking on the landscape of issues shaping the U.S
This information is for educational and informational purposes only, and is not intended to diagnose, treat, cure or prevent any disease
